M Maurer Selected Research

anti-IgE antibodies

8/2023	Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.
9/2015	Omalizumab may not inhibit mast cell and basophil activation in vitro.
6/2015	Management and treatment of chronic urticaria (CU).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Maurer Research Topics

Disease

41	Chronic Urticaria 12/2023 - 04/2004
26	Urticaria (Hives) 07/2023 - 02/2003
14	Angioedema 02/2019 - 11/2011
11	Pruritus (Itching) 11/2022 - 03/2005
11	Inflammation (Inflammations) 01/2020 - 08/2001
8	Hereditary Angioedemas 02/2019 - 07/2012
6	Asthma (Bronchial Asthma) 01/2023 - 06/2006
6	Hypersensitivity (Allergy) 06/2017 - 02/2003
5	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 03/2015
5	Atopic Dermatitis (Atopic Eczema) 01/2020 - 08/2004
5	Cold Urticaria 03/2018 - 12/2007
4	Mastocytosis 01/2015 - 01/2010
4	Allergic Rhinitis 01/2015 - 06/2006
3	Chronic Inducible Urticaria 01/2021 - 01/2016
3	Familial dermographism 11/2019 - 07/2009
2	Rhinitis 01/2023 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2013
2	Schnitzler Syndrome 01/2018 - 07/2012
2	Skin Diseases (Skin Disease) 12/2017 - 07/2009
2	Respiratory Hypersensitivity 07/2017 - 10/2015
2	Acquired angioedema 04/2017 - 01/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2015 - 01/2013
2	Multiple Sclerosis 12/2015 - 10/2008
2	Neoplasms (Cancer) 10/2014 - 01/2008
2	Vasculitis (Vasculitides) 06/2013 - 08/2007
2	Exanthema (Rash) 01/2013 - 12/2012
2	Cryopyrin-Associated Periodic Syndromes 12/2012 - 07/2012
1	Gastroesophageal Reflux (GERD) 05/2022
1	Cryoglobulinemia 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Drug Hypersensitivity (Drug Allergy) 12/2021
1	Hereditary Angioedema Types I and II 12/2021
1	Anaphylaxis (Anaphylactic Shock) 08/2020
1	Wound Infection (Wound Infections) 10/2019
1	Hidradenitis Suppurativa 01/2019
1	Hepatitis 10/2018
1	Asphyxia (Suffocation) 01/2018

Drug/Important Bio-Agent (IBA)

17	Omalizumab (Xolair)FDA Link 08/2023 - 02/2011
15	Histamine Antagonists (Antihistamines)IBA 01/2020 - 01/2008
12	Immunoglobulin E (IgE)IBA 01/2020 - 02/2003
11	Histamine (Histamine Dihydrochloride)FDA Link 12/2023 - 04/2004
8	icatibantIBA 12/2021 - 01/2011
6	BradykininIBA 02/2019 - 11/2011
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2009
6	Cholinergic Agents (Cholinergics)IBA 01/2018 - 02/2008
5	desloratadine (Aerius)FDA LinkGeneric 10/2012 - 04/2008
4	AllergensIBA 01/2023 - 06/2006
4	rupatadineIBA 01/2015 - 04/2008
3	anti-IgE antibodiesIBA 08/2023 - 06/2015
3	bilastineIBA 07/2023 - 07/2013
3	AutoantibodiesIBA 06/2021 - 04/2004
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 07/2013
3	EnzymesIBA 01/2019 - 04/2009
3	miltefosine (Impavido)IBA 03/2013 - 01/2010
3	levocetirizine FDA LinkGeneric 10/2012 - 04/2009
3	Histamine H1 AntagonistsIBA 09/2010 - 07/2009
3	ebastine (Kestin)IBA 07/2009 - 12/2007
2	AntipruriticsIBA 11/2022 - 07/2009
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2015
2	CytokinesIBA 01/2020 - 01/2015
2	SodiumIBA 01/2020 - 03/2010
2	Antiviral Agents (Antivirals)IBA 10/2018 - 10/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 03/2005
2	fibrin fragment D (D-dimer)IBA 01/2018 - 01/2017
2	C-Reactive ProteinIBA 01/2018 - 01/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 04/2009
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2016 - 08/2014
2	Complement System Proteins (Complement)IBA 02/2016 - 12/2000
2	Interleukin-33IBA 01/2015 - 10/2014
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013 - 07/2012
2	Interleukin-1 (Interleukin 1)IBA 12/2012 - 07/2012
2	fexofenadine (Allegra)FDA LinkGeneric 10/2012 - 07/2009
1	Histamine H4 ReceptorsIBA 12/2023
1	Proteinase-Activated ReceptorsIBA 12/2023
1	Monoclonal AntibodiesIBA 08/2023
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 07/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021
1	Polysorbates (PSML)FDA Link 08/2020
1	mepolizumabIBA 08/2020
1	secukinumabIBA 01/2020
1	benralizumabIBA 11/2019
1	Dihydrotachysterol (AT 10)IBA 09/2019
1	Capsaicin (Zostrix)FDA Link 09/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2019
1	Bradykinin B2 ReceptorIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	avoralstatIBA 09/2018
1	Plasma KallikreinIBA 09/2018
1	Kallikreins (Kallikrein)IBA 09/2018
1	Enterotoxins (Enterotoxin)IBA 07/2018
1	reslizumabIBA 03/2018
1	ProteomeIBA 01/2018

Therapy/Procedure

16	Therapeutics 11/2022 - 01/2008
2	Injections 11/2013 - 01/2006